Phase II trial of mapatumumab, a fully human agonistic monoclonal antibody that targets and activates the tumour necrosis factor apoptosis-inducing ligand receptor-1 (TRAIL-R1), in patients with refractory colorectal cancer-Reference-Cited by-同舟云学术

Phase II trial of mapatumumab, a fully human agonistic monoclonal antibody that targets and activates the tumour necrosis factor apoptosis-inducing ligand receptor-1 (TRAIL-R1), in patients with refractory colorectal cancer

Published:2010-01-12 Issue:3 Volume:102 Page:506-512
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Trarbach T,Moehler M,Heinemann V,Köhne C-H,Przyborek M,Schulz C,Sneller V,Gallant G,Kanzler S

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/6605507.pdf

Reference38 articles.

1. Ashkenazi A (2008) Directing cancer cells to self-destruct with pro-apoptotic receptor agonists. Nat Rev Drug Discov 7: 1001–1012

2. Chung KY, Saltz LB (2005) Antibody-based therapies for colorectal cancer. Oncologist 10: 701–709

3. Clemo NK, Collard TJ, Southern SL, Edwards KD, Moorghen M, Packham G, Hague A, Paraskeva C, Williams AC (2008) BAG-1 is up-regulated in colorectal tumour progression and promotes colorectal tumour cell survival through increased NF-kappaB activity. Carcinogenesis 29: 849–857

4. Connolly K, Mitter R, Muir M, Jodrell D, Guichard S (2009) Stable XIAP knockdown clones of HCT116 colon cancer cells are more sensitive to TRAIL, taxanes and irradiation in vitro. Cancer Chemother Pharmacol 64: 307–316

5. Elrod HA, Sun SY (2008) Modulation of death receptors by cancer therapeutic agents. Cancer Biol Ther 7: 163–173

Cited by 165 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Acquired Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) Resistance of Human Colorectal Cancer Cells Is Linked to Histone Acetylation and Is Synergistically Ameliorated by Combination with HDAC Inhibitors;Digestive Diseases and Sciences;2024-08-01

2. Immunomodulatory molecules in colorectal cancer liver metastasis;Cancer Letters;2024-08

3. Targeting apoptotic pathways for cancer therapy;Journal of Clinical Investigation;2024-07-15

4. Targeted treatment of chondrosarcoma with a bacteriophage-based particle delivering a secreted tumor necrosis factor-related apoptosis-inducing ligand;Molecular Therapy: Oncology;2024-06

5. Killer instincts: natural killer cells as multifactorial cancer immunotherapy;Frontiers in Immunology;2023-11-28